Diabetes, obesity & metabolism
The most recent articles from:
January 2018
-
Diabetes Obes Metab · Jan 2018
Randomized Controlled TrialBimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.
To test the hypothesis that an improving body composition in insulin-resistant individuals could enhance insulin sensitivity. ⋯ Taking the observed changes together, and given that these occurred without accompanying dietary intervention and without any prescribed regular physical exercise, bimagrumab may offer a novel approach for the treatment of the metabolic complications of obesity.